Kalsekar A - Search Results

1

Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma.

Crombie JL, Jun M, Wang T, Mutebi A, Wang A, Chhibber A, Kamalakar R, Ukropec J, Blaedel J, Kalsekar A. Crombie JL, et al. Among authors: kalsekar a. Leuk Lymphoma. 2024 Nov;65(11):1623-1633. doi: 10.1080/10428194.2024.2371472. Epub 2024 Jul 16. Leuk Lymphoma. 2024. PMID: 39011744

2

Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma.

Miller SD, Lozano-Ortega G, Mutebi A, Briggs O, Sail K, Elliott B, Kalsekar A. Miller SD, et al. Among authors: kalsekar a. J Comp Eff Res. 2023 Jan;12(1):e220146. doi: 10.2217/cer-2022-0146. Epub 2022 Nov 23. J Comp Eff Res. 2023. PMID: 36417238 Free PMC article. Review.

3

Improvements in Patient-Reported Outcomes in Relapsed or Refractory Large B-Cell Lymphoma Patients Treated With Epcoritamab.

Phillips T, Lugtenburg P, Kalsekar A, Mutebi A, Wang A, Blaedel J, Kosa K, Martin S, Sacchi M, Kilavuz N, Thieblemont C. Phillips T, et al. Among authors: kalsekar a. Clin Lymphoma Myeloma Leuk. 2024 Mar;24(3):e78-e87.e2. doi: 10.1016/j.clml.2023.11.005. Epub 2023 Nov 27. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38151388 Free article.

4

Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis.

Ip A, Mutebi A, Wang T, Jun M, Kalsekar A, Navarro FR, Wang A, Kamalakar R, Sacchi M, Elliott B. Ip A, et al. Among authors: kalsekar a. Adv Ther. 2024 Mar;41(3):1226-1244. doi: 10.1007/s12325-023-02775-9. Epub 2024 Feb 2. Adv Ther. 2024. PMID: 38302846 Free PMC article.

5

Treatment patterns, healthcare resource utilization, and costs in Medicare patients with diffuse large B-cell lymphoma: a retrospective claims analysis (2015-2020).

Jun MP, Mutebi A, Chhibber A, Liang C, Keshishian A, Wang A, Rivas Navarro F, Kalsekar A, He J, Wang T. Jun MP, et al. Among authors: kalsekar a. J Med Econ. 2024 Jan-Dec;27(1):1157-1167. doi: 10.1080/13696998.2024.2399435. Epub 2024 Sep 18. J Med Econ. 2024. PMID: 39254695 Free article.

6

Effect of calorie restriction and intermittent fasting on glucose homeostasis, lipid profile, inflammatory, and hormonal markers in patients with polycystic ovary syndrome: a systematic review.

Kalsekar AS, Abdelrahim DN, Faris ME. Kalsekar AS, et al. Front Nutr. 2024 Apr 5;11:1362226. doi: 10.3389/fnut.2024.1362226. eCollection 2024. Front Nutr. 2024. PMID: 38646104 Free PMC article.

7

An Epidemiological Model to Estimate the Prevalence of Diffuse Large B-Cell Lymphoma in the United States.

Chihara D, Johnston K, Bolatova T, Szabo S, Kalsekar A, Mutebi A, Yang H, Liu Y, Attinson D, Hutchings M. Chihara D, et al. Among authors: kalsekar a. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):e1092-e1099. doi: 10.1016/j.clml.2022.08.008. Epub 2022 Aug 21. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36109323 Free article.

8

Real-World Treatment Patterns and Outcomes Among Patients With Metastatic NSCLC Previously Treated With Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors.

Bains S, Kalsekar A, Amiri KI, Weiss J. Bains S, et al. Among authors: kalsekar a. JTO Clin Res Rep. 2022 Jan 1;3(2):100275. doi: 10.1016/j.jtocrr.2021.100275. eCollection 2022 Feb. JTO Clin Res Rep. 2022. PMID: 35146462 Free PMC article.

9

Pathology Trainee Redeployment and Education During the COVID-19 Pandemic: An Institutional Experience.

Monroig-Bosque PDC, Hsu JW, Lin MS, Shehabeldin AN, Rogers JT, Kim CF, Kalsekar AG, Jin Z, Cara LR, Barbieri AN, El-Zaatari Z, Eskandari G, Sheu TG, Tomsula JA, Long SW, Zieske AW, Leveque CM, Salazar E, Mody DR, Schwartz MR, Cykowski MD, Yi X, Powell SZ, Thomas JS. Monroig-Bosque PDC, et al. Among authors: kalsekar ag. Acad Pathol. 2020 Sep 18;7:2374289520953548. doi: 10.1177/2374289520953548. eCollection 2020 Jan-Dec. Acad Pathol. 2020. PMID: 32995494 Free PMC article.

10

Association of Plasma Levels of Nitric Oxide Oxidative Metabolites with Acute Stroke in Patients Presenting to the Emergency Department of a Low-Middle Income Country.

Waheed S, Kalsekar AG, Kamal AK, Bryan NS, Mian AI. Waheed S, et al. Among authors: kalsekar ag. Emerg Med Int. 2019 Jun 2;2019:9206948. doi: 10.1155/2019/9206948. eCollection 2019. Emerg Med Int. 2019. PMID: 31285918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters